Skip to content

Study of a Carbohydrate Drink in Adults

Postprandial Gastric Emptying and Glycemic Response to a Pre-Operative Carbohydrate Drink in Adults With Pre-diabetes and Type II Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04313920
Enrollment
97
Registered
2020-03-18
Start date
2020-04-07
Completion date
2020-08-26
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Response

Brief summary

The objective of this study is to determine the postprandial glycemic response and rates of gastric emptying in healthy subjects and those with pre-diabetes and type 2 diabetes following oral ingestion of carbohydrate.

Interventions

OTHERNutritional Supplement

50 g Carbohydrate

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject has voluntarily signed and dated an informed consent form and provided Health Insurance Portability and Accountability Act (HIPAA) authorization * Subject is healthy or has pre-diabetes or type 2 diabetes * Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum * Subject's BMI is \> 18.5 kg/m2 and ≤ 40.0 kg/m2 * If subject is on a chronic medication, the dosage has been constant * Subject states willingness to follow protocol

Exclusion criteria

* Subject uses exogenous insulin or Glucagon-like peptide-1 (GLP-1) receptor agonists for glucose control * Subject has type 1 diabetes * Subject has a history of diabetic ketoacidosis * Subject has current infection; has had in-patient surgery, or corticosteroid treatment or antibiotics * Subject has an active malignancy * Subject has had a significant cardiovascular event ≤ six months or history of congestive heart failure * Subject has end-stage organ failure or is status post organ transplant. * Subject has a history of renal disease * Subject has current hepatic disease * Subject has a history of severe gastroparesis * Subject has a chronic, contagious, infectious disease * Subject has taken/is currently taking any herbals, dietary supplements, or medications that could profoundly affect blood glucose * Subject has clotting or bleeding disorders * Subject is known to be allergic or intolerant to any ingredient found in the study products * Subject is a participant in another study that has not been approved as a concomitant study

Design outcomes

Primary

MeasureTime frameDescription
Plasma Glucose ConcentrationBaseline 0 to 240 MinutesArea under the curve

Secondary

MeasureTime frameDescription
Serum Insulin ConcentrationBaseline 0 to 240 MinutesArea under the curve
Nutritional Product AssessmentImmediately following product consumptionSubject completed questionnaire with 2 product liking questions using 7-9 point Likert scale
Subjective Appetitive RatingsBaseline 0 to 240 MinutesSubject completed 4 visual analog scale statements scaled from Not at All to Extremely
Gastric EmptyingBaseline 0 to 180 MinutesRate of gastric emptying

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026